Search research articles
Contact Us
Filters
Showing results (371-380 of 388) with videos related to
Page
of 39
Sort By:
European Heart Journal. Acute Cardiovascular Care
|
June 9, 2017
Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy
Mario Iannaccone, Fabrizio D'Ascenzo, Paolo Vadalà, et al.
Thrombosis and Haemostasis
|
April 4, 2018
Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry
Alberto Garay, Albert Ariza-Solé, Francesc Formiga, et al.
Thrombosis Research
|
August 2, 2018
Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study
Kajetan Grodecki, Zenon Huczek, Piotr Scisło, et al.
American Heart Journal
|
April 15, 2018
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)
Thomas O Bergmeijer, Jean-Luc Reny, Ruth E Pakyz, et al.
Clinical Pharmacology and Therapeutics
|
May 31, 2020
Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium
Shefali Setia Verma, Thomas O Bergmeijer, Li Gong, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
October 6, 2019
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries
Mattia Peyracchia, Andrea Saglietto, Carloalberto Biolè, et al.
International Journal of Cardiology
|
February 7, 2018
Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score
Sergio Raposeiras-Roubín, Jonas Faxén, Andrés Íñiguez-Romo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
September 11, 2019
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients
Joshua P Lewis, Joshua D Backman, Jean-Luc Reny, et al.
European Heart Journal. Acute Cardiovascular Care
|
May 2, 2019
Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention
Sergio Raposeiras-Roubín, Emad Abu-Assi, Berenice Caneiro Queija, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
September 13, 2019
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects
Ovidio De Filippo, Fabrizio D'Ascenzo, Sergio Raposeiras-Roubin, et al.
Page
of 39
Search research articles
Search
Showing results (371-380 of 388) with videos related to
Sort By:
Page
of 39
European Heart Journal. Acute Cardiovascular Care
|
June 9, 2017
Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy
Mario Iannaccone, Fabrizio D'Ascenzo, Paolo Vadalà, et al.
Thrombosis and Haemostasis
|
April 4, 2018
Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry
Alberto Garay, Albert Ariza-Solé, Francesc Formiga, et al.
Thrombosis Research
|
August 2, 2018
Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study
Kajetan Grodecki, Zenon Huczek, Piotr Scisło, et al.
American Heart Journal
|
April 15, 2018
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)
Thomas O Bergmeijer, Jean-Luc Reny, Ruth E Pakyz, et al.
Clinical Pharmacology and Therapeutics
|
May 31, 2020
Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium
Shefali Setia Verma, Thomas O Bergmeijer, Li Gong, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
October 6, 2019
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries
Mattia Peyracchia, Andrea Saglietto, Carloalberto Biolè, et al.
International Journal of Cardiology
|
February 7, 2018
Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score
Sergio Raposeiras-Roubín, Jonas Faxén, Andrés Íñiguez-Romo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
September 11, 2019
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients
Joshua P Lewis, Joshua D Backman, Jean-Luc Reny, et al.
European Heart Journal. Acute Cardiovascular Care
|
May 2, 2019
Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention
Sergio Raposeiras-Roubín, Emad Abu-Assi, Berenice Caneiro Queija, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
September 13, 2019
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects
Ovidio De Filippo, Fabrizio D'Ascenzo, Sergio Raposeiras-Roubin, et al.
Page
of 39